At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of NCI Smoking Intervention Resources
In Brief
A Phase 4 clinical trial evaluating CIS - telephone cessation quitline counseling, Lozenge - nicotine mini-lozenges, and 5 other interventions for Smoking Cessation and 2 related conditions. Completed, enrolled 1,034 participants across 1 site.
Detailed Summary
This is an evaluative study of three National Cancer Institute (NCI) smoking cessation resources: specifically, the smokefree.gov and women smokefree.gov websites, and the CIS counseling phone calls. The following are the identified critical questions: (1). How effective is each of the tobacco interventions (websites \[smokefree.gov \& women smokefree.gov\], NCI's Cessation Quitline counseling services operated by the Cancer Information Service (CIS) (2). How do they compare with alternative intervention strategies? (3). Which types of interventions appear to work best together (due to additive or interactive effects)? (4). How do these interventions work? (5). How much are these interventions used, and what are their relative use rates? (6). Are there important differences in effectiveness or use rates as a function of gender, SES, or other important person factors? We believe that the research study will address all of these questions, as well as some less central ones.
Study Details
Timeline
Interventions
Up to 5 total tobacco cessation counseling calls
2-week starter pack of nicotine mini-lozenges
Brief email messages that could be accessed by any computer or mobile device that allowed email receipt
Over 50 web pages of resources for quitting smoking, including interactive features and referral links
Reduced version of the smokefree.gov website developed for the research; reduced number of web pages and external links (considered a placebo intervention)
NCI's Clearing the Air brochure for preparing to quit, quitting and preventing relapse
12-page booklet developed by the investigators for the research (considered to be placebo intervention)